Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 25% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 27% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1669.53 | 1445 / 1445 | 100% | 14.56 | 183 / 183 |
pancreas | 100% | 1443.74 | 328 / 328 | 100% | 21.65 | 178 / 178 |
prostate | 100% | 4890.42 | 245 / 245 | 100% | 49.10 | 502 / 502 |
thymus | 100% | 2780.31 | 653 / 653 | 100% | 21.84 | 605 / 605 |
uterus | 100% | 2194.47 | 170 / 170 | 100% | 24.59 | 458 / 459 |
liver | 100% | 1307.32 | 226 / 226 | 100% | 16.15 | 404 / 406 |
intestine | 100% | 1500.88 | 963 / 966 | 100% | 19.21 | 525 / 527 |
kidney | 100% | 2054.08 | 89 / 89 | 99% | 17.59 | 894 / 901 |
lung | 100% | 2133.24 | 577 / 578 | 99% | 19.56 | 1148 / 1155 |
bladder | 100% | 1492.52 | 21 / 21 | 99% | 23.23 | 499 / 504 |
breast | 100% | 2180.06 | 458 / 459 | 99% | 18.22 | 1106 / 1118 |
stomach | 100% | 1686.33 | 359 / 359 | 99% | 17.14 | 282 / 286 |
adrenal gland | 100% | 2135.29 | 258 / 258 | 98% | 20.62 | 226 / 230 |
ovary | 100% | 2914.83 | 180 / 180 | 98% | 14.41 | 422 / 430 |
brain | 100% | 2628.18 | 2632 / 2642 | 90% | 12.65 | 637 / 705 |
skin | 91% | 1859.16 | 1644 / 1809 | 98% | 20.75 | 464 / 472 |
eye | 0% | 0 | 0 / 0 | 100% | 32.90 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 12.57 | 29 / 29 |
spleen | 100% | 2180.34 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 20.94 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 27.17 | 1 / 1 |
blood vessel | 100% | 1704.70 | 1331 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 1382.97 | 1200 / 1204 | 0% | 0 | 0 / 0 |
muscle | 99% | 1873.81 | 798 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 1407.37 | 824 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 87% | 834.22 | 804 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0021782 | Biological process | glial cell development |
GO_0034316 | Biological process | negative regulation of Arp2/3 complex-mediated actin nucleation |
GO_0042149 | Biological process | cellular response to glucose starvation |
GO_0050796 | Biological process | regulation of insulin secretion |
GO_0015844 | Biological process | monoamine transport |
GO_0006890 | Biological process | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum |
GO_0006886 | Biological process | intracellular protein transport |
GO_0060292 | Biological process | long-term synaptic depression |
GO_0036294 | Biological process | cellular response to decreased oxygen levels |
GO_0002092 | Biological process | positive regulation of receptor internalization |
GO_0043113 | Biological process | receptor clustering |
GO_0097061 | Biological process | dendritic spine organization |
GO_0045161 | Biological process | neuronal ion channel clustering |
GO_0097062 | Biological process | dendritic spine maintenance |
GO_0006468 | Biological process | protein phosphorylation |
GO_0034315 | Biological process | regulation of Arp2/3 complex-mediated actin nucleation |
GO_0007205 | Biological process | protein kinase C-activating G protein-coupled receptor signaling pathway |
GO_0098842 | Cellular component | postsynaptic early endosome |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0030666 | Cellular component | endocytic vesicle membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0043005 | Cellular component | neuron projection |
GO_0042734 | Cellular component | presynaptic membrane |
GO_0032588 | Cellular component | trans-Golgi network membrane |
GO_0005829 | Cellular component | cytosol |
GO_0008021 | Cellular component | synaptic vesicle |
GO_0045202 | Cellular component | synapse |
GO_0014069 | Cellular component | postsynaptic density |
GO_0005737 | Cellular component | cytoplasm |
GO_0005080 | Molecular function | protein kinase C binding |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0005543 | Molecular function | phospholipid binding |
GO_0051015 | Molecular function | actin filament binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0071933 | Molecular function | Arp2/3 complex binding |
GO_0001664 | Molecular function | G protein-coupled receptor binding |
GO_0140090 | Molecular function | membrane curvature sensor activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PICK1 |
Protein name | Protein interacting with PRKCA 1 PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein) |
Synonyms | PRKCABP |
Description | FUNCTION: Probable adapter protein that bind to and organize the subcellular localization of a variety of membrane proteins containing some PDZ recognition sequence. Involved in the clustering of various receptors, possibly by acting at the receptor internalization level. Plays a role in synaptic plasticity by regulating the trafficking and internalization of AMPA receptors. May be regulated upon PRKCA activation. May regulate ASIC1/ASIC3 channel. Regulates actin polymerization by inhibiting the actin-nucleating activity of the Arp2/3 complex; the function is competitive with nucleation promoting factors and is linked to neuronal morphology regulation and AMPA receptor (AMPAR) endocytosis. Via interaction with the Arp2/3 complex involved in regulation of synaptic plasicity of excitatory synapses and required for spine shrinkage during long-term depression (LTD). Involved in regulation of astrocyte morphology, antagonistic to Arp2/3 complex activator WASL/N-WASP function. . FUNCTION: Probable adapter protein that bind to and organize the subcellular localization of a variety of membrane proteins containing some PDZ recognition sequence. Involved in the clustering of various receptors, possibly by acting at the receptor internalization level. Plays a role in synaptic plasticity by regulating the trafficking and internalization of AMPA receptors. May be regulated upon PRKCA activation. May regulate ASIC1/ASIC3 channel. Regulates actin polymerization by inhibiting the actin-nucleating activity of the Arp2/3 complex; the function is competitive with nucleation promoting factors and is linked to neuronal morphology regulation and AMPA receptor (AMPAR) endocytosis. Via interaction with the Arp2/3 complex involved in regulation of synaptic plasicity of excitatory synapses and required for spine shrinkage during long-term depression (LTD). Involved in regulation of astrocyte morphology, antagonistic to Arp2/3 complex activator WASL/N-WASP function. . |
Accessions | F6V3V1 ENST00000437453.5 ENST00000424694.5 F6VY12 F6V107 ENST00000435166.1 E7EX80 ENST00000426258.5 ENST00000432756.6 ENST00000404072.7 [Q9NRD5-1] F6TII1 ENST00000445628.5 Q9NRD5 ENST00000356976.8 [Q9NRD5-1] |